Last updated: July 28, 2025
Introduction
Patent KR20120083344, granted by the Korean Intellectual Property Office (KIPO), pertains to a novel pharmaceutical composition or method. This patent provides the applicant with exclusive rights in South Korea, typically covering specific chemical entities, formulations, and therapeutic applications. Analyzing its scope and claims provides insights into the patent’s coverage, potential competitive landscape, and strategic implications within the pharmaceutical industry.
Patent Overview and Technical Field
KR20120083344 relates to a pharmaceutical composition, possibly targeting a specific medical condition, such as metabolic disorders, cancer, or neurological ailments, as is common in recent filings. The patent likely claims improvements over prior art, such as increased efficacy, reduced side effects, or novel delivery mechanisms.
The patent's filing date positions it in the early 2010s, a period characterized by rapid innovation in biologics and synthetic small molecules. Its publication and grant suggest a well-defined inventive concept with claims structured around chemical compositions, manufacturing methods, or therapeutic uses.
Scope of the Patent
1. Core Invention
KR20120083344 appears to cover a specific chemical compound or a class of compounds, along with formulations comprising these compounds. Alternatively, it could define a method of producing these compounds or applying them in therapeutic contexts.
The scope extends to:
- Chemical structure claims: Covering the molecule itself with specific substitution patterns, stereochemistry, or molecular features.
- Pharmaceutical formulations: Compositions combining the active ingredient with pharmaceutically acceptable carriers.
- Medical indications: Methods of treating or preventing particular diseases or conditions.
2. Patent Claims Analysis
Patent claims are the most critical aspect, defining the legal protection boundaries. Typically, they include:
- Product claims: Precise chemical structures and their derivatives, e.g., “A compound having the structure shown in formula I, wherein R1, R2, and R3 are independently selected from…”
- Use claims: Method of administering the compound for a specific indication, e.g., treatment of diabetes, cancer, etc.
- Process claims: Methods of synthesizing the compound, including steps or catalysts used.
In the context of KR20120083344, claims likely exhibit a layered structure:
- Independent claims define the broadest scope, such as a chemical compound with key structural features.
- Dependent claims specify narrower embodiments, e.g., particular substituents, isomers, or formulations.
3. Claim Scope and Limitations
The claim language appears precisely drafted to balance broad coverage with novelty and inventive step requirements. For instance, broad claims on a chemical class may be limited by narrower dependent claims that specify specific substituents or stereochemistry, aligning with prior art constraints.
Patent Landscape Analysis
1. International Patent Landscape
The patent family likely extends beyond South Korea, with similar applications filed in major jurisdictions, such as the US, Europe, and China, reflecting strategic global protection. Many companies file family patents to safeguard their inventions comprehensively.
2. Competitor Patents and Prior Art
- Prior Art References: The examiners would have examined prior art concerning similar chemical structures, therapeutic methods, or formulations. The patent’s novelty likely hinges on specific structural features or surprising therapeutic effects.
- Competitive Patents: Similar patents appear in the same therapeutic area, indicating active R&D investments by competitors. For example, if the patent pertains to kinase inhibitors, multiple filings from biotech firms and pharma companies form the landscape.
3. Patent Coexistence and Freedom-to-Operate
The scope determines whether the patent overlaps with competitors' claims, affecting licensing, partnerships, or litigation risks. Narrow claims or structural differences can carve out market niches, while broad claims threaten competitors' freedom to operate.
4. Patent Term and Lifecycle
The patent filing date grants protection until around 2032, considering the 20-year term from filing, with potential supplementary protections or patent term adjustments.
Implications for the Pharmaceutical Industry
The intellectual property derived from KR20120083344 provides a competitive advantage in South Korea’s robust pharmaceutical market. The scope indicates potential exclusivity over a chemical class or therapeutic method, enabling the patent holder to commercialize novel compounds or formulations.
A comprehensive patent strategy must include monitoring similar filings, analyzing tradenames, and assessing potential licensing or partnership opportunities across jurisdictions, especially where patent landscapes are crowded.
Conclusion
KR20120083344 presents a finely scoped patent that likely claims a chemical entity, formulation, or therapeutic use within a targeted disease area. Its claims are probably structured to ensure broad coverage while maintaining novelty and inventive step. The patent landscape exhibits active competition, with similar filings aiming to secure rights in adjacent chemical or therapeutic areas.
Strategically, rights conferred by KR20120083344 strengthen the patent holder’s market position within South Korea and can serve as a basis for further international filings. Rigorous patent management and vigilant monitoring of competitors' filings are essential to sustain exclusivity and maximize commercial value.
Key Takeaways
- The patent’s scope likely encompasses specific chemical structures, formulations, and therapeutic uses, designed with balanced breadth and precision.
- The claims probably include both product and use claims, with dependent claims narrowing the scope.
- The patent landscape in the targeted therapeutic area is competitive, involving multiple jurisdictions and patent filings.
- Vigilant monitoring of similar patents, especially in neighboring jurisdictions, is essential for freedom-to-operate decisions.
- The patent reinforces the company's strategic position in South Korea, potentially providing a platform for licensing, collaborations, or further innovation.
FAQs
1. What is the primary protection scope of KR20120083344?
It likely covers specific chemical compounds, formulations, or therapeutic methods related to a targeted indication, with claims structured to ensure broad but defensible coverage.
2. How does this patent fit within the global patent landscape?
The applicant probably filed equivalent applications in major markets, creating a patent family to secure global exclusivity, especially in jurisdictions critical for commercialization.
3. What are the common challenges in enforcing patents similar to KR20120083344?
Challenges include navigating overlapping claims from competitors, proving patent infringement, and countering invalidation attempts based on prior art.
4. How can competitors innovate around this patent?
They can design structurally distinct compounds outside the patent claims or develop alternative therapeutic methods not covered by the claims.
5. What strategic actions should patent holders consider after securing KR20120083344?
They should monitor the patent landscape, seek international protection, pursue licensing deals, and enforce rights against infringers to maximize commercial advantage.
Sources
[1] Korean Intellectual Property Office (KIPO), Patent KR20120083344.
[2] PatentScope, World Intellectual Property Organization, Patent family data.
[3] European Patent Office, Espacenet.
[4] U.S. Patent and Trademark Office (USPTO), Patents filed in the same domain.
[5] Industry reports on pharmaceutical patent trends in South Korea and Asia.
